Thank you very much, and hello, everyone. I'll use a couple of slides which will just cover some thoughts about the report, and then we'll move to questions. The structure of the portfolio has, of course, been changed somewhat, but the overall bigger names are still the bigger names. Babylon has been revalued for obvious reasons, and that is slightly a larger part of the portfolio now, which is exciting. Voi and Gett have, together with Babylon, increased at the expense of BlaBlaCar, which is down a little bit. The overall structure of the portfolio is one that you're familiar with. In terms of the overview of this NAV, so $11.36 per share, which the dollar has fallen, so it's only SEK 93 or just under SEK 93 per share. If you adjust for the rights issue, that's up 22% year-on-year. Big contributors in this last quarter, as across the year, Babylon and Voi have been standouts, have been clear beneficiaries of the COVID situation we're arguably still in. Gett has been a contributor in this last quarter, and BlaBlaCar we've taken down a bit. Come back to BlaBlaCar because we really think that's going to be a very interesting trajectory in front of itself now that we're going into, hopefully, the last inning of this COVID. Overall, the portfolio changed about just under $190 million upwards. That's a change in NAV. Most of the NAV is mark-to- model right now. Our models are we look out over the near-term financials and apply a peer group multiple. In some cases, the peer group becomes very logical, and in some other cases, there is nothing like our portfolio companies out there in the listed world, so it becomes more of a larger group that hopefully, collectively gets us the best peer group we can. We have put some money to work during the quarter. Babylon, the main one, where we put together an SPV of totally $100 million. We put in $35 million. The biggest new investment is HungryPanda, which is a Delivery Hero for overseas Chinese communities. Laser focus on that community, which is a large community and perhaps growing given the stuff that's happening in some parts around that country. Also follow-ons in Voi and Booksy. Booksy has real ly made a big step change here with attracting serious international money, American money, driven by the presence that they have now clearly demonstrated, especially in the U.S., but obviously Poland is also a large part of that. I think if we just go company by company here and touch upon that quickly. Babylon, all of you know, of course, in an aggregated level, is just under $400 million in our NAV now. We own just shy of 11% of the company. During the fourth quarter, they delivered 11,500 daily consultations. That is up nearly 50% year-on-year. Overall, global registrations have reached 6.7 million, which is up from 3.8 million as per year-end 2019. As could be expected, lots of activity around that company, but lots and lots of activity to come. The company's really doing heavy lifting in securing very large contracts, predominantly with their existing clients. That will really propel them into a completely different sort of revenue base over these next two years. I'll come back to that a little bit later. BlaBlaCar, as you know, is the one that of our larger holdings has perhaps most negatively affected during COVID, and that remains now. It lightened up a little bit during the easing during the summer, but as you know, large parts of Europe, people are now at home. In the fourth quarter, they had just under 21 million passengers. That's down like 43% year-on-year, quarter-on-quarter is up. We see activity, especially in their emerging markets, have really picked up over this last quarter, which is very positive to see. It's also very interesting to see that they are in a relative situation, relative to their competitors, which is mainly buses because there's no one else doing this on the C2C car side of things. Relative to their competitors on the bus side, they are in such a good spot because obviously long-distance travel has fallen. Today, people travel much less long distance than they did pre-COVID. That's going to change, hopefully, with vaccinations and us getting out of this pandemic. The travel that does happen, that happens in a car. People are not willing to spend time on a bus or a train. The activity level of long distance basically happens in a car and on the BlaBlaCar C2C car network. They also possess all long-distance operation that goes on a third-party sort of relationship. That puts them in possession of data that their competitors doesn't have. Of course, BlaBla's own bus network, that's also closed, like their competitors. The car side of things is really holding things up. They're very well-financed, and they have a very interesting sort of 2021 ahead of themselves as competition suffers and may also give rise to interesting opportunities. On Voi. Voi, I think we may have spoken about also in this sort of forum, but despite all these restrictions that we've had during the year, Voi grew its total number of rides by 50%. Their success, I think we can allow ourselves to describe it as in the U.K., has really propelled them into becoming the absolute leader in this space in Europe. That put them on the radar screen of large U.S. institutions who were on the sidelines waiting for which European scooter platform would pull away as the winner. Voi has now done that with their success in the U.K., where they're basically taking 80% of the licenses issued. That enabled them to complete this funding round that we also talked about in December last year. They raised a total of $160 million led by Raine Group of California, and that revalued our investment in the company upwards from the lower valuation that was put in the midst of the early COVID days when visibility also into travel inside the city was much lower. Going on here, we have Gett, the valuation is up 18% during the quarter. It's primarily driven by that the market multiples have been going upwards. We are now present on the board. I'm on the board of Gett. I'm really fascinated by the speed of which they're delivering their new product, which is a SaaS product to their business clients and really puts them in a different sort of pocket, equity story-wise, et cetera, compared to their competitors which are all pure ride hailing. Sort of in the tennis maniac kind of description that I make of myself, I think I'm a tennis maniac, and my attempt to map out our entire portfolio in tennis players, that all really comes from that I've found myself more and more describing three darlings in the portfolio as our next generation players. Next generation those players who are still young, they may not even be in the top 100, so more risky, but there's some of those that will be the next sort of Nadals of this world. There's three of them in our portfolio, Booksy, Swvl, and Dostavista. We think all three of them are around $200 million, some a little bit more, some a little bit less. We own around 15%. I think all of those will double and double again over the next three years in their funding rounds. The businesses are growing. They will need funding. They will attract increasingly larger check kind of investors. Collectively, they could be like $100 million, sorry, $1 billion each of them. Us owning 15%, they collectively could start to approach half a billion dollars, $500 million in our portfolio as visibility grows over these three years and funding rounds are completed. We don't talk much about them today, because they're small in relation to those large ones, but these will come out of the shadows of Babylon and BlaBlaCar and Voi in the same way as those companies did from Avito. Swvl is disrupting intercity public transportation in large emerging market cities, starting in Cairo, going elsewhere. If I had to choose amongst the ones, this would probably be the standout one. We own 13% of that. Booksy, SaaS-driven booking platform, which is going into a marketplace type of business, just completed a round where actually our friends at Sprints invested alongside some Americans. Cat Rock Capital led a SEK 70 million funding round in the company which closed just now, and we participated, took our pro rata. We own about 10%. Dostavista is this last mile delivery service which offers on-demand logistics for SMEs. Started in Russia, it's growing very fast in primarily Asia. We don't talk much about ESG and sustainability here in this format, but we are doing an enormous amount of work on that as everyone else. We're not doing it because we are, I mean, for our operations, although we will start to report by GRI standards now. We will comply fully with that. I think it's just worth noting that all our investments are business model that sort of hinges on our offer or product to consumers that are completely sort of conscious over these different elements of ESG. Although we sort of monitor it when we enter and when we are present at these portfolio companies' boards, their products are driven by this from day one. BlaBlaCar has delivered 1.6 million tons of carbon savings. Voi is, of course, lower CO2 per kilometer than anyone else. Babylon is offering healthcare with the help of Bill & Melinda Gates Foundation to large parts of Africa. Gett sort of in the similar fashion to Voi, it's a very climate efficient way to run transportation in these cities. I think the only other sort of point I'd like to make before we go over to Q&A is, of course, that I note where we're trading in relation to our NAV, and I've only noted this, when this has happened in our previous sort of history, it's usually been when one of our portfolio companies has been in the run up to an IPO. It happens from time to time. I think we are very conscious of building a portfolio that's difficult for our typical shareholders to access themselves. We think our portfolio has the potential to deliver a lot of value over the longer term. As you know, we're very long-term shareholders. Although our NAV should be put together so it reflects a fair value, we think it leaves a lot of upside. Us trading above that, I don't think it's odd by any measure. I think it's noticeable that it seems to sort of coincide clear runs above our NAV coincides with portfolio companies going public. I think there may be some sort of I think as you've all seen, there are IPO sort of listing ambition across quite a few of our portfolio companies, not driven by us. We're not going to exit the main ones. We are here for the long term. We will sell when the founders sell. For some companies, it makes sense from an operational sort of standpoint to become public. Of course, without going into any details or if it may happen or not happen, it's just clear that there's a big price discrepancy in the market where Babylon is active between public and private holdings. Obviously, a listing sort of environment would allow a company like Babylon to gain a currency for M&A, which is something that they're already engaged with now funding out of their balance sheet. When we value a company like Babylon now with a model, we have a peer group that we think is relevant. It's relevant here because mostly they're involved in some sort of fashion in digital health. There's none in the peer group that is as technologically advanced or offers the same sort of product and with the same sort of prospect as Babylon. I think it's fair to say that I think the median multiple that we get is like 12x on revenues. We look on that, and then we discount that because Babylon's not listed, et cetera. I think, though, if you remember, if Babylon were to list and a public market investor would look at it, I think it's easy to put together a scenario where you look at the presentation that Babylon showed us at our Capital Markets Week last year. That had projections of a $900 million revenue base during 2022. Now, that's large growth and that needs to be delivered, and there's risk with everything. Things could be delayed, things could also come earlier. The company's performing well and things are rolling on to plan. If you take, I think the cleanest maybe, at least in terms of digital health exposure in the U.S., I think a company like Teladoc, if you take that kind of multiple and look out a year on revenues approaching $1 billion, you of course get to values of Babylon that they are nowhere near where we have them in our mark. Where we have them makes sense. We look not so distant in the future. We look nearer in the future, and we use a multiple that comes from an average, from a median of a peer group that involves companies with maybe a multiple level that are not relevant for Babylon. I think that's important to note. If this company were to go public at some point, then I think there's some argument that maybe we trade at, not a premium, but a discount and a large discount. I think with that note, I think I'll leave it over to questions, and if the operator could help us handle that would be great. Thank you. Ladies and gentlemen, if you do wish to ask a question, please press zero one on your telephone keypad now. That is zero one to register for a question. We have a question from the line of Ramil Koria from SEB. Please go ahead. Your line is open. Thank you, operator. Thank you, Per, for the presentation and for taking my questions. Just two, if I may, on Babylon. First off, apologies if you've already mentioned it, with the new convertible financing, should we consider Babylon fully financed for the time being? How should we consider the financing situation now post the convertible? Yes, the convertible certainly helps, or the convertible is our financing. We put together an SPV that predominantly consists of a convertible that will convert into equity at the valuation of their next funding round with a discount, which I think is attractive. We hold $35 million of that $100 million financing, and other investors holds the rest. To your question, is that money together with some other, maybe not funding rounds, but sort of operational deals that they're doing, the company is funded under some scenarios all the way to sort of becoming EBITDA positive. Having said that, there's lots of opportunities out there for a company like Babylon. That may change. They're in a good situation now in terms of funding, and they don't have to rush into anything. There's lots of activity which may have them looking up funding rounds of different sorts. That's very clear. Just a slight follow-up on that. Could you just remind me about your policy in terms of owning public companies? If Babylon, the other shareholders are pushing for a potential IPO, how would you go about in such a scenario where an IPO did materialize? What we have traditionally done when a company long term, we will not own stuff that is listed. We feel that our shareholders, be it large Swedish or international institutions or Swedish retail, they can do that themselves in a very efficient way now. Long term, we are not holders. We note that we're close to the company, and should it go public now, our rule of thumb is that we sell when the founders sell. I think even if this company should go public now at even double where we have it at, it leaves such a large upside. I'm quite sure that the founder won't sell any stock, and hence that box of ours, that rule of thumb of ours is not ticked. Long term, I think it doesn't make sense for us to hold listed stocks. What we've done in the past is that in some cases where we felt that there was a clear upside, we've dividended out these holdings to shareholders pretty quickly. In other cases, I think Avito is a good example, when they IPO-ed in 2013, we sold into that IPO because we felt the price was full. We don't have anything in our charter which sort of tells us that we have to sell into an IPO, or we have to distribute. We can hold listed things. We just don't think it makes sense to do that long term. That's very clear. A final one from me, perhaps on the operational side on Babylon again. We listened to Ali on your Capital Markets Week, saying that the company aims at having an annual recurring revenue of $600 million by year-end. I haven't, to my knowledge, seen any deal announcements since. Could you just take us through, first off, if any contracts indeed have been won? Then secondly, if they haven't, you touched upon it yourself, but why are we seeing a slight delay in contract wins? No. They're delivering their contracts. They're live with a couple of new contracts during the autumn. From getting live, they will also expand, and then revenues will start to show. Pretty much all their growth in revenue over these coming years are all sourced from expansion of existing commercial relationships, existing clients, that's to say. Obviously Centene in the U.S., NHS U.K., Prudential, Southeast Asia are three large clients where they have expanding relationships. Those are all on plan. It's not Babylon being a private company, I'm not sure that they all become public, those relationships. I think what's fair to say from where I am, things are on plan. It takes a long time to put these contracts together, and then a contract is one thing, and then it takes time also to start to implement and transform a contract into actual revenues. The risk of those revenues coming in is very low once you have a contract signed, but there's still a time gap between that. I think that's all pretty much in hand as per plan from the company, so delivering well there. Right. That's encouraging. Thank you. Bye. I remind you that if you want to ask a question, please press 01 on your telephone keypad now. We have a question from the line of Stefan Wård from Pareto Securities. Please go ahead. Okay. Thank you. A couple of questions or three actually small questions, if I may. Just if you could repeat the outlook for the three growth investments that you highlighted in the presentation. I didn't follow exactly on the valuation potential that we saw there. Maybe you can start with that. Yes. Those three are, I did it in a perhaps a too back-of-the-envelope or high-level way, but what I did say was that they're all around $200 million. Dostavista is a little bit lower. Swvl and Booksy are higher. I mean, in Booksy, quite a bit higher, but around $200 million, certainly on an average basis. From that basis, I think, yeah, they all have the potential to double and then double again as they, over three years, complete probably two more funding rounds, which in each funding round, I think will have the potential to be double of the previous one because these companies are growing so fast. It's a risk with everything, and this could be wrong. I could turn out to be wrong. For where we are now, I think that's entirely possible. Hence 200 goes to 400 goes to 800, of course. If you allow yourself the sketchy rounding up to a $1 billion each, then us owning 15% of that gets you to about a $450 million collective value of those three. Very high level, Stefan. I think that the growth and that they will be able to perform strongly over the next 36 months and double and double again, I think it's entirely possible. Collectively, it could be like a half a billion-dollar part of our portfolio across three companies bigger than Babylon is today. Over three years, I think Babylon will be nowhere near where it is today, of course. Anyway, that was the logic. Perfect. Thank you very much. Onto the next question is a little bit about, I haven't seen, but if you could give, do you have a rough ballpark of annual investment needs, or is that not a relevant measure for you, like the CapEx budget, or it depends on? Yeah, sure. I think we don't typically supply that. The only company we know that will raise a round this year and that we know we will want to participate is Swvl. Swvl is growing very fast. They have large opportunities across Middle East, Asia, and now Latin America. That company, I think you'll see doing $100 million round. We own 15% of it. That's probably not until later in the year, but if there are good deals to be done earlier, that's something we have our eyes on and we're very close to the company. My colleague, Björn, is on the board. That's one we know. Most others are funded in terms of operations. There is some exception. Obviously Babylon got some money from us and got some money from another route as well. Voi is very funded, Gett funded. BlaBla has a large balance sheet. Swvl will be the standout. I think there may be opportunities in the portfolio, for example, around something like BlaBlaCar, who is so strong in relation to their competitors, and there is so many opportunities out there. They are on their knees. It certainly does not need to raise any money for defensive reasons. They have a very large cash pile for that on their balance sheet. They have a great opportunity to become more aggressive. There may be funding needs in the portfolio for aggressive reasons. Those also come. They are priced differently, of course, if they are done for aggressive reasons rather than defensive reasons. We continuously look for new investments. We have the scout program going now, where we have four or five scouts who are building portfolios of 5-10 names each. We hope that will, over the course of this year, generate a portfolio of 40, 50 different names, which will be very small, and we won't talk about them until they come into the next round or the next round, where we have the optionality to enter directly into the cap table rather than via our scout programs. In the very early days, those checks are very small. On an aggregate level, they're still small. It's more to have exposure to those companies from a young stage. When they grow older, they become more relevant, and hence also the check sizes are bigger. We have lots of activity going on there, but we're also looking at new investments in our space. Okay. A last question also relating to Babylon. I fully agree that Babylon looks a bit conservative value if compared to how it could be priced in the market today. You mentioned a figure there, like 12 billion. Given what your view on the prospects of Babylon, and if we just assume that the prevailing valuations are sustainable for that segment, where would you be a seller? What's the potential for Babylon, say, in a five-year format, would you say? If you would like to put the figure out there. I don't think we'd be a seller of this below $20 billion. That would be in the current sort of environment. If you look over this year and next year, I think the revenue growth of that company will prove up those sort of valuations. Then beyond that, there will be upside. Their addressable market in the U.S. is close to $1 trillion. I'm not saying that they're going to take all that, but there's a large market to gun for, and they're offering something that no one else is. The multiples that their listed peers are trading at, they obviously factor in a lot of growth. I think Babylon sort of stands out as they will be able to deliver at least the same growth as their competitors, and likely more because of their products being so unique in many ways. Yeah. It's really interesting. Thank you, Per. Thanks. Thank you. As a final reminder, if you would like to ask a question, please press zero one on your telephone keypad now. There are no further questions registered. I hand back to the speaker. Thank you very much for your participation here, everyone, and let us know if there is anything else we can help you with. Otherwise, we will talk to you in three months. Okay. Bye-bye.